Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
ClearNote Health Launches Early Detection Test for Pancreatic Cancer
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
Turning Physics into a Diagnostic Signal for Bladder Cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
FDA Releases Personalized Medicine Report
...
Already a member? Log in here
Electronic Laboratory Reporting Advancing, But Greater Adoption Needed
...
Already a member? Log in here
Inappropriate Test Ordering Practices Driving Health Care Costs
...
Already a member? Log in here
G2 Insider: Guideline Adherence Could Drive Thyroid Function Testing
...
Already a member? Log in here
Protein Markers May Eliminate Need for Biopsies in Infertile Men
...
Already a member? Log in here
PGx Adoption Still Slow; Outcomes Benefits Inconclusive
...
Already a member? Log in here
National Sequencing Efforts Aim to Boost Use of Genomic Information
...
Already a member? Log in here